Share Email Print
cover

Proceedings Paper • new

Novel metal-based photosensitizers for photodynamic therapy: exploratory study (Conference Presentation)

Paper Abstract

Ruthenium and osmium-based photosensitizers (PS) are compounds of interest for use in photodynamic therapy (PDT). These PS’s can be activated by light wavelengths in the range of 400-675 nm, which can be selected based on the tumor environment, treatment area, and available light sources. The objective of this study was to explore these PS’s for the treatment of several relatively aggressive cancer cell lines. A human adenocarcinoma cell line (A549) was treated with ruthenium-based compounds at concentrations of 1, 5, or 10 uM, followed by light treatment of 93 J/cm2 at either 532 nm or 630 nm. Similarly, osmium-based compounds were used to treat A549, murine melanoma (B16F10) and squamous cell carcinoma (SCCVII) cell lines at concentrations of 0.05, 1, or 3 uM, followed by light treatment of 93 J/cm2 at 630 nm. Cells survival was assessed 24 hours after PDT treatment using either alamarBlue or MTT cell viability assays. In-vitro MTT viability assays revealed that ruthenium-based compounds activated with 630 nm light showed high SCCVII cell toxicity at 5uM. AlamarBlue assays have shown that ruthenium based compounds activated by 532 nm light show high A549 cell toxicity at 1uM in-vitro. Osmium-based compounds showed optimal PDT-mediated cytotoxicity in SCCVII, A549, and B16F10 cell lines at a concentration of 1uM activated by 630 nm light, while exhibiting minimal dark toxicity. The Ruthenium and Osmium-based compounds are potentially potent PSs against lung, melanoma and squamous cell carcinoma cells, in-vitro.

Paper Details

Date Published: 14 August 2019
PDF
Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110701U (14 August 2019); doi: 10.1117/12.2526180
Show Author Affiliations
Lindsey Carlsen, Roswell Park Comprehensive Cancer Ctr. (United States)
Taylor Mandeville, Roswell Park Comprehensive Cancer Ctr. (United States)
Patrick Barrett, The Univ. of North Carolina at Greensboro (United States)
Evan Bradner, The Univ. of North Carolina at Greensboro (United States)
Tariq Sainuddin, The Univ. of North Carolina at Greensboro (United States)
Sherri McFarland, The Univ. of North Carolina at Greensboro (United States)
Sarah Chamberlain, Roswell Park Comprehensive Cancer Ctr. (United States)
David Bellnier, Roswell Park Comprehensive Cancer Ctr. (United States)
Gal Shafirstein, Roswell Park Comprehensive Cancer Ctr. (United States)


Published in SPIE Proceedings Vol. 11070:
17th International Photodynamic Association World Congress
Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top